Cargando…
Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML
Acute myeloid leukemia (AML) is a deadly heterogeneous hematologic malignancy. Despite the well-characterized genetic characteristics and new promising targeted therapies for AML, the clinical outcome remains suboptimal. Galectin-9 (Gal-9) is a good potential target due to its immunosuppressive capa...
Autores principales: | Zhang, Yongping, Xue, Song, Hao, Qi, Liu, Fuhong, Huang, Wenqiu, Wang, Jingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176406/ https://www.ncbi.nlm.nih.gov/pubmed/34093826 http://dx.doi.org/10.7150/jca.53686 |
Ejemplares similares
-
OLFML2A Overexpression Predicts an Unfavorable Prognosis in Patients with AML
por: Lu, Xuan, et al.
Publicado: (2023) -
Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma
por: Elhawary, Nasser A, et al.
Publicado: (2023) -
PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
por: Liu, Jun, et al.
Publicado: (2022) -
Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers
por: Geoffroy, Karen, et al.
Publicado: (2023) -
PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis
por: Kwon, Chae Hwa, et al.
Publicado: (2016)